Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001056520-11-000290
Filing Date
2011-08-15
Accepted
2011-08-15 13:43:20
Documents
9
Period of Report
2011-06-30

Document Format Files

Seq Description Document Type Size
1 cellcyteform10qjune302011fin.htm 10-Q 277602
2 exhibit31.htm EX-31 12314
3 exhibit32.htm EX-32 4976
  Complete submission text file 0001056520-11-000290.txt   1402021

Data Files

Seq Description Document Type Size
4 ccyg-20110630.xml EX-101.INS 164171
5 ccyg-20110630.xsd EX-101.SCH 7625
6 ccyg-20110630_cal.xml EX-101.CAL 4915
7 ccyg-20110630_def.xml EX-101.DEF 52686
8 ccyg-20110630_lab.xml EX-101.LAB 87215
9 ccyg-20110630_pre.xml EX-101.PRE 66850
Mailing Address PMB189 14205 SE 36TH, SUITE 100 BELLEVUE WA 98006
Business Address PMB189 14205 SE 36TH, SUITE 100 BELLEVUE WA 98006 425-519-3755
CELLCYTE GENETICS CORP (Filer) CIK: 0001325279 (see all company filings)

EIN.: 861127046 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-52238 | Film No.: 111034921
SIC: 2834 Pharmaceutical Preparations